{
    "2021-12-22": [
        [
            {
                "time": "",
                "original_text": "上海医药：公司是国内拥有罕见病药品批文最多的企业之一",
                "features": {
                    "keywords": [
                        "上海医药",
                        "罕见病药品",
                        "批文"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "来自广州，越洋医药完成1.5亿元C轮增资",
                "features": {
                    "keywords": [
                        "越洋医药",
                        "C轮增资",
                        "1.5亿元"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}